Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.11B Buy
68,616,393
+6,573,236
+11% +$201M 1.01% 12
2016
Q3
$1.99B Sell
62,043,157
-1,225,790
-2% -$41M 1% 11
2016
Q2
$2.11B Buy
63,268,947
+582,328
+0.9% +$18.6M 1.1% 8
2016
Q1
$1.76B Buy
62,686,619
+3,324,438
+6% +$95M 0.95% 15
2015
Q4
$1.82B Sell
59,362,181
-988,922
-2% -$31.1M 1% 10
2015
Q3
$1.8B Buy
60,351,103
+723,314
+1% +$23.2M 1.05% 9
2015
Q2
$1.9B Sell
59,627,789
-3,313,382
-5% -$108M 1.03% 9
2015
Q1
$2.08B Sell
62,941,171
-3,583,767
-5% -$114M 1.12% 7
2014
Q4
$1.97B Buy
66,524,938
+2,713,239
+4% +$77.8M 1.05% 10
2014
Q3
$1.79B Sell
63,811,699
-1,417,187
-2% -$39.8M 1.04% 10
2014
Q2
$1.84B Buy
65,228,886
+2,098,057
+3% +$59.8M 1.06% 10
2014
Q1
$1.92B Buy
63,130,829
+342,103
+0.5% +$10.2M 1.21% 7
2013
Q4
$1.82B Sell
62,788,726
-6,733,100
-10% -$196M 1.18% 9
2013
Q3
$1.89B Buy
69,521,826
+1,403,482
+2% +$38.2M 1.27% 7
2013
Q2
$1.81B Buy
+68,118,344
New +$1.88B 1.37% 6

Other funds holding PFE

BlackRock Group's PFE Position: Q4 2016 in Review

BlackRock Group increased its Pfizer (PFE) stake by 11% in Q4 2016, buying an estimated $201M and bringing the position to 68,616,393 shares worth $2.11B. The position accounts for 1.01% of the portfolio, ranked #12.

BlackRock Group first reported a position in PFE in Q2 2013 and has held it in 15 quarters since. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

  • BlackRock Group held 68,616,393 shares of Pfizer worth $2.11B as of Q4 2016.
  • BlackRock Group bought 6,573,236 Pfizer shares in Q4 2016, an estimated $201M.
  • Pfizer made up 1.01% of BlackRock Group's portfolio in Q4 2016, its #12 holding.
  • BlackRock Group first reported a position in Pfizer in Q2 2013 and has held it in 15 quarters since.
  • 2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.